Z Squared ZSQR
NASDAQ ZSQR
$3.98 +0.38 (+10.69%)
As of: Oct 22, 2026 · 11:40 AM EDT

Z Squared (ZSQR) EBIT Margin (2025 - 2026)

Updated

Z Squared's EBIT Margin was -871.15% in Q2 2026, up 2569.66 percentage points from the prior quarter.

Analysis

Z Squared (ZSQR) EBIT Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Z Squared's EBIT Margin was -792.87% through Jun 30, 2026, up 12505.13 percentage points year-over-year; for FY2025, it was -956.94%.

  • EBIT Margin shows a four-year change of +17770.97 percentage points (FY2021 to FY2025).
  • In earlier years, EBIT Margin was -18727.91% in FY2021.
  • Quarterly EBIT Margin has moved between -6452.56% (Q1 2025) and -230.64% (Q4 2025) over five years.
  • Per Business Quant data, ZSQR's EBIT Margin in the three quarters before Q2 2026 was -3440.81% (Q1 2026), -230.64% (Q4 2025) and -1043.22% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn 28.21%
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn 37.86%
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn -3.52%
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn 32.97%
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn 20.57%
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn -133.21%
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn 28.37%
10 Z Squared 197.54 Mn 170.78 Mn -1.77 Mn -871.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -871.15%
Mar 31, 2026 -3,440.81%
Dec 31, 2025 -230.64%
Sep 30, 2025 -1,043.22%
Mar 31, 2025 -6,452.56%
API Access

Z Squared EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZSQR&period=max&api_key=YOUR_API_KEY